Local Regulatory Experts
Connect with regulatory affairs consultancies specializing in this region.
Qualtech Consulting Corporation
Taiwan, China, Japan, Singapore, Hong Kong, Malaysia, Philippines, Vietnam, Australia, Germany, Korea, Thailand, USA
A specialized medical device consulting firm offering a one-stop solution for complex global regulatory challenges. We offer real-time regulatory and clinical support, local representation, and QMS services across 13 markets, ensuring efficient market entry and compliance.
Registrar Corp
Hampton, Virginia (HQ), Shenzhen, China, London, United Kingdom, Paris, France, Madrid, Spain, Hyderabad, India, Kuala Lumpur, Malaysia, Tel Aviv, Israel, Guatemala City, Guatemala, Cape Town, South Africa
A global FDA compliance firm assisting businesses in the food, medical device, drug, and cosmetic industries with registration, U.S. Agent services, labeling, and regulatory software solutions.
ARQon Pte. Ltd.
Singapore (HQ), Malaysia, Vietnam, Indonesia, Philippines, Thailand, Taiwan, Hong Kong, South Korea, Switzerland, USA, Australia, New Zealand, Rwanda, India, Sri Lanka
We are a premier regulatory consultancy firm specializing in medical devices, in-vitro diagnostics (IVD), and pharmaceuticals. Founded in 2014, the company offers a comprehensive suite of services ranging from product development strategy and clinical trials to product registration and post-market surveillance. With a team of experts possessing vast experience in regulatory authorities and industry, we bridge the gap between scientific innovation and regulatory compliance, ensuring patient safety while fostering medical advancement. The company also provides unique business matching services through its ATTOPOLIS platform and training through the International Medical Device School.
MDREX, Medical Device, Digital Health Consulting Group
Seoul, Republic of Korea (HQ), Japan Office
We offer total solutions for market entry in South Korea and global expansion (e.g., Japan, USA, Europe). Key areas include product approval, reimbursement listings (HIRA), and Quality System certification (KGMP). They are particularly strong in innovative products like SaMD, medical wearables, and 3D printing for medical use, and provide in-depth expertise in cybersecurity and clinical trial planning.
August 16, 2025
Approximately 5 minutes
Regulations on Unique Device Identification (UDI) Management in South Korea (MFDS Notice No. 2019-46)
Regulations on Unique Device Identification (UDI) Management in South Korea (MFDS)
South Korea’s Ministry of Food and Drug Safety (MFDS) issued MFDS Notice No. 2019-46 (established June 12, 2019) to define the details of what medical device manufacturers and importers must register in the national UDI system, including the scope of required information, registration procedures, and update rules. MFDS also publishes this regulation as part of its official English regulatory resources. ([mfds.go.kr][1])
1) Purpose and legal basis
The notice exists to operationalize the UDI-related obligations under the Medical Devices Act and its Enforcement Rule, by specifying:
- what UDI/device information must be registered,
- who must register it,
- and the method and procedures for registration. ([eLaw][2])
2) Who must register, and where
Medical device manufacturers and importers (including for imported devices, information on foreign manufacturers) are required to register prescribed information in the UDI System, via electronic means such as the Internet, when they release a device that has been licensed, certified, or notified.
3) What must be registered in the UDI System
The regulation groups mandatory registration items into three buckets.
A) UDI information (identification + barcode standard)
Manufacturers/importers must register:
- UDI-DI (Device Identifier), and
- the barcode labeling system used (choose from GS1, HIBCC, ICCBBA).
B) Product information (packaging, control, safety flags, licensing, tracking)
Required product-level fields include (selected highlights):
- total quantity in packaging
- for standalone software, software version
- management format: lot/serial/manufacture date/expiry date
- sterile status and (if applicable) sterilization requirement and sterilization method (e.g., autoclave, EO gas, etc.)
- whether it is a national health insurance benefit item and (if applicable) benefit code
- fatal warnings/contraindications flags (e.g., latex, DEHP/phthalates for fluid sets, MRI safety)
- implantable, single-use
- item name, class, license/certificate/notification number and date, product/model name
- whether subject to tracking; and set/composite device component item name/class
C) Manufacturer/importer information (including foreign manufacturer details)
Required company-level fields include:
- UDI management contact (phone/email)
- manufacturer/importer name and addresses, including contracted manufacturer (if any), and for imports the foreign manufacturer’s name/address
4) Optional information you may register (when needed)
The regulation allows (but does not require) additional fields such as:
- storage conditions,
- distribution/handling conditions,
- URL for further product description including electronic IFU (e-IFU),
- package DI,
- customer service desk information.
5) Exemptions: when some items can be skipped
If certain information is already linked through MFDS’s license information system, the notice allows exemptions from registering:
- some product information items (the notice references items (j) through (s) within the product list), and
- certain manufacturer/importer information items (the notice references items (b) through (f) within the company list).
6) Updates, confidentiality, and governance
Registering changes
When specified registered information changes, manufacturers/importers must register the changes in the UDI System within 10 days after the date of change (the notice points to defined subsets of product and contact information).
Confidentiality obligations
Anyone who learns confidential manufacturer or product information (company secrets) through their work must not disclose it or use it for non-business purposes.
Re-review cycle
The regulation’s validity is to be reviewed every three years (from January 1, 2019; by Dec 31 of every third year) with improvement measures taken as needed.
7) Phased enforcement timeline (by device class)
The addenda specify phased entry into force:
- Class IV: July 1, 2019
- Class III: July 1, 2020
- Class II: July 1, 2021
- Class I: July 1, 2022
This phased approach is also reflected in the Enforcement Rule’s addenda for provisions tied to UDI-related requirements. ([eLaw][2])
Practical compliance tips (sponsor/manufacturer checklist)
- Decide your issuing agency format early (GS1 vs HIBCC vs ICCBBA) and ensure your UDI-DI and labeling match.
- Map internal PLM/ERP fields to MFDS UDI data fields (sterility, sterilization method, warnings like latex/DEHP/MRI safety, implantable/single-use).
- For imported devices, prepare foreign manufacturer identifiers/address data and UDI contact ownership.
- Put a change-control trigger in your QMS to ensure UDI updates are filed within 10 days when relevant fields change.
- If you publish e-IFU, register the URL (optional) and maintain version control so the URL remains valid over time.
Q&A
Q1. What exactly must be registered for the UDI itself?
At minimum, the UDI-DI and the selected barcode labeling system (GS1/HIBCC/ICCBBA).
Q2. Are software-only medical devices covered?
The notice explicitly calls out that for standalone software, the software version must be registered as part of product information.
Q3. What if my device is sterile or needs sterilization before use?
You must indicate whether it is sterile, whether it requires sterilization before use, and (if yes) the sterilization method from the listed options (e.g., autoclave, EO gas).
Q4. How quickly do I need to update the UDI system when something changes?
For specified fields, changes must be registered within 10 days after the change date.
Q5. Is there any relief if MFDS already has my information in another system?
Yes—where certain information is linked through MFDS’s license information system, parts of the registration may be exempted as described in the notice.
Q6. When did UDI requirements start applying to each class?
They were phased in from July 1, 2019 (Class IV) through July 1, 2022 (Class I).
References
- Regulations on Unique Device Identification Management, Etc.* (MFDS Notice No. 2019-46).
- MFDS official English regulations listing. ([mfds.go.kr][1])
- Korea Law (KLRI e-Law): Enforcement Rule of the Medical Devices Act (shows phased enforcement provisions). ([eLaw][2])
Have a Question?
Ask our experts about this topic. We'll do our best to respond to your question.
Related Articles
Approximately 5 minutes
Approval Process for Medical Devices in South Korea (MFDS Overview)
An MFDS overview of South Korea’s premarket pathways (notification, certification, approval), the required technical documentation (including SER when clinical trial reports are needed), review timelines, business licensing for manufacturers/importers, and tracking-control obligations for high-risk devices.
Approximately 5 minutes
Guiding Principles for Conducting Clinical Trials for Machine Learning-enabled Medical Devices (MLMD) in South Korea (MFDS–HSA)
MFDS (Korea) and HSA (Singapore) jointly issued guiding principles (first released Dec 11, 2024) to address MLMD-specific clinical study challenges, covering trial design, dataset representativeness and independence, reference standards and adjudication, and endpoint analysis with justified acceptance criteria.
Approximately 5 minutes
Guidance for Additional Considerations to Support Conformity Assessment of In Vitro Companion Diagnostic Medical Devices in South Korea
This guidance explains how South Korea expects in vitro companion diagnostics (IVD-CDx) to be developed, labelled, and supported with analytical and clinical performance evidence for conformity assessment—including scenarios such as follow-on tests, new specimen types, and class/group labelling.
Approximately 5 minutes
Regulation on the Permission, Notification, Review, Etc. of Medical Devices in South Korea (MFDS Public Notification No. 2022-52)
South Korea’s MFDS Public Notification No. 2022-52 details how to file manufacturing/import permission, certification, or notification for medical devices, how technical documents are reviewed (including staged review), and how to manage post-approval changes—forming a practical playbook for conformity assessment.